title: Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.
authors.forename: C
authors.initials: C
authors.lastname: Léauté-Labrèze
authors.forename: E
authors.initials: E
authors.lastname: Dumas de la Roque
authors.forename: F
authors.initials: F
authors.lastname: Nacka
authors.forename: A
authors.initials: A
authors.lastname: Abouelfath
authors.forename: N
authors.initials: N
authors.lastname: Grenier
authors.forename: M
authors.initials: M
authors.lastname: Rebola
authors.forename: K
authors.initials: K
authors.lastname: Ezzedine
authors.forename: N
authors.initials: N
authors.lastname: Moore
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002921:Cicatrix / Q000517:prevention & control; D004311:Double-Blind Method; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010865:Pilot Projects; D011433:Propranolol / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011433:Propranolol